These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30282862)

  • 1. Urinary Exosomal mRNA of WT1 as Diagnostic and Prognostic Biomarker for Diabetic Nephropathy.
    Abe H; Sakurai A; Ono H; Hayashi S; Yoshimoto S; Ochi A; Ueda S; Nishimura K; Shibata E; Tamaki M; Kishi F; Kishi S; Murakami T; Nagai K; Doi T
    J Med Invest; 2018; 65(3.4):208-215. PubMed ID: 30282862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy.
    Sakurai A; Ono H; Ochi A; Matsuura M; Yoshimoto S; Kishi S; Murakami T; Tominaga T; Nagai K; Abe H; Doi T
    PLoS One; 2019; 14(5):e0216788. PubMed ID: 31150422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wilm's tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuria.
    Kalani A; Mohan A; Godbole MM; Bhatia E; Gupta A; Sharma RK; Tiwari S
    PLoS One; 2013; 8(3):e60177. PubMed ID: 23544132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary podocyte-associated mRNA profile in Egyptian patients with diabetic nephropathy.
    Fayed A; Rahman Tohamy IA; Kahla H; Elsayed NM; El Ansary M; Saadi G
    Diabetes Metab Syndr; 2019; 13(5):2849-2854. PubMed ID: 31425946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms' tumor-1 protein used as a podocyte marker.
    Su J; Li SJ; Chen ZH; Zeng CH; Zhou H; Li LS; Liu ZH
    Diabetes Res Clin Pract; 2010 Feb; 87(2):167-75. PubMed ID: 19969384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
    Zubiri I; Posada-Ayala M; Sanz-Maroto A; Calvo E; Martin-Lorenzo M; Gonzalez-Calero L; de la Cuesta F; Lopez JA; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
    J Proteomics; 2014 Jan; 96():92-102. PubMed ID: 24211404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WT1 and ACE mRNAs of blood extracellular vesicle as biomarkers of diabetic nephropathy.
    Hashemi E; Dehghanbanadaki H; Baharanchi AA; Forouzanfar K; Kakaei A; Mohammadi SM; Zeidi S; Razi F
    J Transl Med; 2021 Jul; 19(1):299. PubMed ID: 34246281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of diabetic nephropathy, the present and the future.
    Jim B; Santos J; Spath F; Cijiang He J
    Curr Diabetes Rev; 2012 Sep; 8(5):317-28. PubMed ID: 22698077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophy and loss of podocytes in diabetic nephropathy.
    Miyauchi M; Toyoda M; Kobayashi K; Abe M; Kobayashi T; Kato M; Yamamoto N; Kimura M; Umezono T; Suzuki D
    Intern Med; 2009; 48(18):1615-20. PubMed ID: 19755763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.
    Lioudaki E; Stylianou KG; Petrakis I; Kokologiannakis G; Passam A; Mikhailidis DP; Daphnis EK; Ganotakis ES
    Nephron; 2015; 131(1):34-42. PubMed ID: 26340089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
    Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
    PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular signal-regulated kinase is activated in podocytes from patients with diabetic nephropathy.
    Yamashiro A; Satoh Y; Endo S; Oshima N
    Hum Cell; 2024 Sep; 37(5):1553-1558. PubMed ID: 39052150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy.
    Wan J; Hou X; Zhou Z; Geng J; Tian J; Bai X; Nie J
    Free Radic Biol Med; 2017 Jul; 108():280-299. PubMed ID: 28315733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy.
    Wang G; Lai FM; Lai KB; Chow KM; Li KT; Szeto CC
    Nephron Clin Pract; 2007; 106(4):c169-79. PubMed ID: 17596726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary exosomes and diabetic nephropathy: a proteomic approach.
    Raimondo F; Corbetta S; Morosi L; Chinello C; Gianazza E; Castoldi G; Di Gioia C; Bombardi C; Stella A; Battaglia C; Bianchi C; Magni F; Pitto M
    Mol Biosyst; 2013 Jun; 9(6):1139-46. PubMed ID: 23344851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte apoptosis in diabetic nephropathy by BASP1 activation of the p53 pathway via WT1.
    Zhang Y; Xu C; Ye Q; Tong L; Jiang H; Zhu X; Huang L; Lin W; Fu H; Wang J; Persson PB; Lai EY; Mao J
    Acta Physiol (Oxf); 2021 May; 232(1):e13634. PubMed ID: 33615732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semaphorin3a promotes advanced diabetic nephropathy.
    Aggarwal PK; Veron D; Thomas DB; Siegel D; Moeckel G; Kashgarian M; Tufro A
    Diabetes; 2015 May; 64(5):1743-59. PubMed ID: 25475434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes.
    Zubiri I; Posada-Ayala M; Benito-Martin A; Maroto AS; Martin-Lorenzo M; Cannata-Ortiz P; de la Cuesta F; Gonzalez-Calero L; Barderas MG; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
    Transl Res; 2015 Nov; 166(5):474-484.e4. PubMed ID: 26072307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte mRNA in the urinary sediment of minimal change nephropathy and focal segmental glomerulosclerosis.
    Szeto CC; Wang G; Chow KM; Lai FM; Ma TK; Kwan BC; Luk CC; Li PK
    Clin Nephrol; 2015 Oct; 84(4):198-205. PubMed ID: 26308082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.